refractory PTCL

Related by string. * Refractory : relapsed refractory multiple myeloma . hormone refractory prostate cancer . refractory Hodgkin lymphoma . refractory anemia . refractory multiple myeloma . relapsed refractory AML . rituximab refractory follicular . refractory rituximab naive / PTCLs : PTCL privatization . cell lymphoma PTCL . cell Lymphoma PTCL . PTCL landline . PTCL . Limited PTCL * *

Related by context. Frequent words. (Click for all words.) 66 pralatrexate 65 FOLOTYN 63 tamibarotene 61 perifosine 61 cutaneous T cell 61 HGS ETR1 60 L MTP PE 60 HRPC 60 hematological malignancies 60 picoplatin 60 Perifosine 59 carfilzomib 59 metastatic colorectal cancer 59 Clolar 59 tivozanib 59 NGX# 59 Marqibo 58 vandetanib 58 TREANDA 58 Zerenex 58 ofatumumab 58 AP# [003] 58 hormone refractory prostate cancer 57 Genasense 57 brentuximab vedotin 57 MGCD# [001] 57 oncology indications 57 ZYBRESTAT 57 IMGN# 57 PEGINTRON 57 advanced NSCLC 57 monotherapy 57 orBec R 56 ALN VSP 56 BENLYSTA 56 ASA# 56 NSCLC 56 Taxotere R 56 Pixantrone 56 CTCL 56 voreloxin 56 metastatic melanoma 56 relapsing forms 56 RG# [001] 56 pixantrone 56 dasatinib 56 relapsing remitting multiple sclerosis 56 clofarabine 56 relapsed 56 sorafenib 55 ZEVALIN 55 dimebon 55 gemcitabine 55 Torisel 55 LymphoStat B 55 docetaxel 55 ABRAXANE 55 pemetrexed 55 blinatumomab 55 Marketing Authorization Application 55 panitumumab 55 ADVEXIN 54 resistant ovarian cancer 54 Vectibix 54 Azixa 54 disease modifying 54 INCB# [002] 54 cetrorelix 54 Vidaza 54 satraplatin 54 Satraplatin 54 XL# [003] 54 Phase Ib 54 Mozobil 54 GATTEX 54 Phase 2b study 54 myelofibrosis 54 taxane 54 tesetaxel 54 hyperuricemia 54 solid tumors 54 Phase IIb trial 54 hepatocellular carcinoma HCC 54 hematologic malignancies 54 sunitinib 54 pegylated interferon 54 gefitinib 54 ThermoDox 54 Phase 2a trial 54 Ceplene 54 Bronchitol 54 cytarabine 54 PRX # 53 DAVANAT R 53 erlotinib 53 oxaliplatin 53 ENMD 53 KRYSTEXXA 53 T DM1 53 Phase IIa trial 53 PEG INTRON

Back to home page